Table 2.

Baseline patient and tumor characteristics.

Characteristic	Number of Patients (%)
Sex Male Female	14 (42,4%) 19 (57,6%)
Histology Adenocarcinoma	33 (100 %)
Location of lesion Pancreatic head Pancreatic neck Body Tail Overlapping head/neck Overlapping head/body Overlapping body/tail	15 (45,5%) 4 (12,1%) 4 (12,1%) 1 (3,0%) 3 (9,1%) 3 (9,1%) 3 (9,1%)
Stage T T2 T3 T4	6 (18,2%) 15 (45,5%) 12 (36,3%)
Stage N N0 N1 N2	25 (75,8%) 6 (18,1%) 2 (6,1%)
Stage M M0	33 (100 %)
Tumor classification Borderline (BRPC) Locally advanced pancreatic cancer (LAPC)	13 (39,4%) 20 (60,6%)
Adjacent organ invasion(duodenum) No	33 (100 %)
Neoadjuvant chemotherapy FOLFIRINOX Gemcitabine-nab-paclitaxel (Abraxane)	17 (51,5 %) 16 (48,5%)